Biomarkers for chronic heart failure : diagnostic, prognostic, and therapeutic challenges
- PMID: 20024637
- DOI: 10.1007/s00059-009-3316-4
Biomarkers for chronic heart failure : diagnostic, prognostic, and therapeutic challenges
Abstract
Cardiac biomarkers are very important in diagnosis, risk stratification, and management of patients with heart failure. Although not meeting all criteria for an ideal biomarker, natriuretic peptides primarily have a diagnostic and prognostic role. Other routinely available and newly emerging biomarkers have a complementary role in patient management; thus multimarker strategy might be warranted in future. The quest for a single marker or a combination is ongoing and several established, widely available biomarkers might have been overlooked in the field of heart failure. The authors review some of those biomarkers and speculate on the possible roles of combining two or more of them.
Similar articles
-
Natriuretic Peptides in Clinical Practice.Anatol J Cardiol. 2019 Mar;21(Suppl 1):1-40. doi: 10.14744/AnatolJCardiol.2019.55623. Anatol J Cardiol. 2019. PMID: 30860204 Review.
-
Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.Int J Cardiol. 2009 Mar 6;132(3):303-11. doi: 10.1016/j.ijcard.2008.11.149. Epub 2009 Jan 13. Int J Cardiol. 2009. PMID: 19144431
-
Natriuretic peptides in the diagnosis and management of chronic heart failure.Heart Fail Clin. 2009 Oct;5(4):501-14. doi: 10.1016/j.hfc.2009.04.002. Heart Fail Clin. 2009. PMID: 19631175 Free PMC article. Review.
-
Management of chronic heart failure: biomarkers, monitors, and disease management programs.Ann Glob Health. 2014 Jan-Feb;80(1):46-54. doi: 10.1016/j.aogh.2013.12.005. Epub 2013 Dec 25. Ann Glob Health. 2014. PMID: 24751564 Review.
-
[Cardiac biomarkers in the critically ill].Med Klin Intensivmed Notfmed. 2012 Feb;107(1):17-23. doi: 10.1007/s00063-011-0028-3. Epub 2012 Jan 6. Med Klin Intensivmed Notfmed. 2012. PMID: 22349473 Review. German.
Cited by
-
Use of multiple biomarkers in heart failure.Curr Cardiol Rep. 2010 May;12(3):230-6. doi: 10.1007/s11886-010-0109-6. Curr Cardiol Rep. 2010. PMID: 20424966 Review.
-
Renal biomarkers of kidney injury in cardiorenal syndrome.Curr Heart Fail Rep. 2011 Jun;8(2):99-105. doi: 10.1007/s11897-011-0052-x. Curr Heart Fail Rep. 2011. PMID: 21380936 Review.
-
Synthesis of dinucleoside tetraphosphates in transfected cells by a firefly luciferase reporter gene.Cell Mol Life Sci. 2004 Feb;61(4):497-501. doi: 10.1007/s00018-003-3420-1. Cell Mol Life Sci. 2004. PMID: 14999408 Free PMC article.
-
Biomarker and no end to it?Herz. 2009 Dec;34(8):579-80. doi: 10.1007/s00059-009-3319-1. Herz. 2009. PMID: 20024635 No abstract available.
-
A year in heart failure: an update of recent findings.ESC Heart Fail. 2021 Dec;8(6):4370-4393. doi: 10.1002/ehf2.13760. Epub 2021 Dec 16. ESC Heart Fail. 2021. PMID: 34918477 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical